Lawmakers Urge MedPAC To Rethink Imaging Cuts
This article was originally published in The Gray Sheet
Executive Summary
MedPAC's recent votes favoring policy changes intended to further reduce imaging utilization and spending are misguided, two lawmakers argue in a recent letter to the commission.
You may also be interested in...
MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending
The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.